Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23182627 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy
Condition: Unresectable Hepatocellular Carcinoma
Interventions: Drug: ARQ 197;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.